Expert Review of Vaccines

Potential prophylaxis for SARS
pp. 413-414(2)

Preclinical trial success with new influenza vaccines
pp. 415-415(1)

Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine
pp. 417-430(14)
Author: Keitel, Wendy A

Prevention of shingles by varicella zoster virus vaccination
pp. 431-443(13)
Author: Holodniy, Mark

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135
pp. 445-459(15)
Authors: Keyserling, Harry L; Pollard, Andrew J; DeTora, Lisa M; Gilmet, Gregory P

Are tick-borne encephalitis vaccines interchangeable?
pp. 461-466(6)
Authors: Bröker, Michael; Schöndorf, Ines

Can leukemia-derived dendritic cells generate antileukemia immunity?
pp. 467-472(6)
Authors: Rosenblatt, Jacalyn; Avigan, David

Vaccination against malaria with live parasites
pp. 473-481(9)
Authors: Rénia, Laurent; Grüner, Anne Charlotte; Mauduit, Marjorie; Snounou, Georges

Live attenuated oral cholera vaccines
pp. 483-494(12)
Authors: Ryan, Edward T; Calderwood, Stephen B; Qadri, Firdausi

Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccination
pp. 495-503(9)
Authors: Song, Xiao-Tong; Aldrich, Melissa; Chen, Si-Yi

Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development
pp. 505-516(12)
Authors: Betts, Michael R; Gray, Clive M; Cox, Josephine H; Ferrari, Guido

Prospects for a vaccine against otitis media
pp. 517-534(18)
Authors: Cripps, Allan W; Otczyk, Diana C

Investigating the association between influenza vaccination and reduced stroke risk
pp. 535-540(6)
Authors: Lichy, Christoph; Grau, Armin J

Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy
pp. 541-552(12)
Authors: Singh, Reshma; Paterson, Yvonne

Pneumococcal conjugate vaccines: emerging clinical information and its implications
pp. 553-564(12)
Authors: Lockhart, Stephen P; Hackell, Jill G; Fritzell, Bernard

Pneumococcal conjugate vaccines: emerging clinical information and its implications
pp. 553-564(12)
Authors: Lockhart, Stephen P; Hackell, Jill G; Fritzell, Bernard

The potential role of fowlpox virus in rational vaccine design
pp. 565-577(13)
Authors: Beukema, Emma L; Brown, Michael P; Hayball, John D

Corrigendum
pp. 578-578(1)

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
pp. 579-595(17)
Authors: Haynes, Barton F; Montefiori, David C